Model N introduces new rebate enhancement

Model N has introduced a critical product enhancement that supports evolving compliance needs around the Inflation Reduction Act, IRA. The company has introduced a new Medicare Part D inflation rebate-per-unit, ensuring pharma manufacturers remain compliant with impending IRA regulation and avoid significant revenue loss. “The Inflation Reduction Act introduces sweeping changes for drug pricing and Medicare programs, and our goal is to empower customers to stay ahead of these shifts,” said Suresh Kannan, Chief Product Officer at Model N. “As our life sciences customers prepare for new reforms and regulatory changes, Model N’s latest product innovations address a critical market need by providing the capabilities necessary to calculate and process complex Medicare Part D inflation rebates.”